Grown Rogue International (GRUSF) Share-based Compensation (QoQ) (2012 - 2026)
Grown Rogue International (GRUSF) Share-based Compensation (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00% |
| Dec 31, 2025 | -200.00% |
| Sep 30, 2025 | 30,619,206,454.59% |
| Jun 30, 2025 | -99.55% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | -175,455,960.56% |
| Sep 30, 2024 | 948.67% |
| Jun 30, 2024 | -63.32% |
| Oct 31, 2023 | 50.33% |
| Jul 31, 2023 | 102.21% |
| Apr 30, 2023 | 71.81% |
| Jan 31, 2022 | -80.54% |
| Oct 31, 2021 | 238.11% |
| Jul 31, 2021 | -139.55% |
| Apr 30, 2021 | -20.71% |
| Jan 31, 2021 | 335.69% |
| Oct 31, 2020 | -82.28% |
| Jul 31, 2020 | 35.57% |
| Apr 30, 2020 | 362.67% |
| Jan 31, 2020 | 1,502.01% |